The role of hepatocyte-specific staining in liver pathology. (June 2011)

• Record Type: Journal Article
• Authors: Filippone, Antonella; Cianci, Roberta; Patriarca, Guido; Sabatino, Federica; Tartaro, Armando; Cotroneo, Antonio Raffaele
• Is Part Of: Expert review of gastroenterology & hepatology. Volume 5:Number 3(2011)
• Page Start: 353
• Page End: 363
• Publication Date: 2011-06
• Subjects: Eovist®® -- Gd-BOPTA -- Gd-EOB-DTPA -- hepatocyte-specific contrast agent -- liver lesion -- MultiHance®® -- MRI -- Primovist®®; Gastroenterology -- Periodicals; Liver -- Diseases -- Periodicals; 616.3
• DOI: 10.1586/egh.11.32
• Languages: English
• ISSNs: 1747-4124

Abstract

The advantages of MRI in the investigation of liver disease are well documented. Recent developments, including fast scanning technique and new MRI contrast agents, enable improved detection and characterization of focal liver lesions. Therefore, a definitive diagnosis can be made avoiding invasive procedures, such as liver biopsy. In this article, a special emphasis is placed on the clinical use of combined perfusional and hepatocyte-selective MRI contrast agents, which allow us to obtain morphologic and vascular information, owing to the dynamic study, as well as functional information, owing to the hepatocyte-selective phase of enhancement. Different clinical scenarios are considered in order to highlight the proper use of the hepatocyte phase to noninvasively characterize and detect different focal liver lesions.